EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Implementation of quality indicators for ovarian cancer in gynecological cancer centers certified by the German Cancer Society (DKG)

Carla E Schulmeyer, Birgit Klages, Martin Utzig, Frederik A Stuebs, Olaf Ortmann, Pauline Wimberger, Beyhan Ataseven, Nina Pauly, Matthias W Beckmann, Julius Emons, Patrik Pöschke

Journal of Cancer Research and Clinical Oncology · 18.11.2026

DOI: 10.1007/s00432-026-06644-0 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 18.11.2026. Verfasst von Carla E Schulmeyer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Quality Indicators, Health Care, Cancer Care Facilities. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Erlangen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Since 2008, the German Cancer Society (DKG) has certified gynecological cancer centers to ensure high-quality care with guideline-based quality indicators (QI) as a core component. This article summarizes the German development and update of ovarian cancer (OC) QI based on the current S3-guideline (2026) and presents their performance.

Methods

This was a retrospective, descriptive, observational analysis of aggregated annual-report data for treatment years 2019–2024; no inferential statistics were performed. QI were derived from strong S3-guideline recommendations through a structured multi-step process. Experts identified potential QI according to standardized criteria (including feasibility and impact on care). QI required ≥ 75% agreement. Since 2017, each tumor entity has been limited to five key QI in the certification dataset.

Results

Eight guideline-derived QI are currently defined for OC, five QI are included in the certification program. In 2024, 184 certified centers treated 4.951 primary OC cases. At center level, the predefined target values were met for surgical staging (93.5% of centers; target ≥ 40%), offering genetic testing (97.8%; target ≥ 70%), complete macroscopic resection (99.5%; target ≥ 30%), and surgery by a gynecologic oncologist (98.9%; target ≥ 80%). All centers (100%) met plausibility limits for first-line chemotherapy (75.1% of advanced-stage patients). At patient level, pooled adherence rates improved over time; the median rate of offering genetic testing rose from 61% (2019) to 84% (2024). Two QI were retired in 2021, and one QI is pending until further guideline updates.

Conclusion

Guideline-based QI translate essential recommendations into measurable metrics, allowing objective assessment of quality. High and increasing adherence rates were observed in certified centers. These findings support the use of guideline-based QI for benchmarking and continuous quality improvement, although the observational design precludes causal attribution to certification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsQuality Indicators, Health CareCancer Care FacilitiesFemaleHumansRetrospective StudiesGermanyCertificationSocieties, MedicalPractice Guidelines as Topic

Stichwörter der Autor:innen

Certified gynecological cancer centersOvarian cancerQuality indicatorS3-guideline

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
  • Comprehensive Cancer Center Alliance WERA (CCC WERA), Erlangen, Germany.
  • Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Department for Certification, German Cancer Society, Kuno-Fischer-Strasse 8, 14057, Berlin, Germany.
  • Department of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.

Förderung

  • Universitätsklinikum Erlangen

Zitieren

APA

Schulmeyer, C. E., Klages, B., Utzig, M., Stuebs, F. A., Ortmann, O., Wimberger, P., Ataseven, B., Pauly, N., Matthias W Beckmann, Emons, J., & Pöschke, P. (2026). Implementation of quality indicators for ovarian cancer in gynecological cancer centers certified by the German Cancer Society (DKG). Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-026-06644-0

Vancouver

Schulmeyer CE, Klages B, Utzig M, Stuebs FA, Ortmann O, Wimberger P, et al. Implementation of quality indicators for ovarian cancer in gynecological cancer centers certified by the German Cancer Society (DKG). Journal of Cancer Research and Clinical Oncology. 2026. doi:10.1007/s00432-026-06644-0

BibTeX
@article{Schulmeyer2026,
  author = {Schulmeyer, Carla E and Klages, Birgit and Utzig, Martin and Stuebs, Frederik A and Ortmann, Olaf and Wimberger, Pauline and Ataseven, Beyhan and Pauly, Nina and Matthias W Beckmann and Emons, Julius and Pöschke, Patrik},
  title = {Implementation of quality indicators for ovarian cancer in gynecological cancer centers certified by the German Cancer Society (DKG)},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2026},
  doi = {10.1007/s00432-026-06644-0}
}
Kostenlos starten →